Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

77 results about "Genus Kluyveromyces" patented technology

Kluyveromyces is a genus of ascomycetous yeasts in the family Saccharomycetaceae. Some of the species, such as K. marxianus, are the teleomorphs of Candida species.

Efficient CRISPR/Cas (Clustered Regulatory Interspaced Short Palindromic Repeats/CRISPR associated) 9 gene editing system for Kluyveromyces optimization

ActiveCN107574179AStable gene editingEfficient gene editingFungiMicroorganism based processesBiotechnologyTime transformation
The invention relates to a special safe and efficient CRISPR / Cas (Clustered Regulatory Interspaced Short Palindromic Repeats / CRISPR associated) 9 gene editing system for Kluyveromyces optimization, and belongs to the field of biotechnology. In the prior art, pCAS plasmids used in saccharomyces cerevisiae have Cas9 gene sequences and gRNA (guide RNA) elements at the same time, and efficient genomemodification in the saccharomyces cerevisiae can be realized through one-time transformation, but stable copying and expression cannot be realized in Kluyveromyces. According to the system, Cas9 / gRNAfusion plasmids are transformed in Kluyveromyces cells, the plasmids are targetedly delivered to endogenous DNA sequences of the Kluyveromyces cells, and double strand breaks are generated; and donorDNA sequences are transformed in the Kluyveromyces cells, the sequences generate homologous recombination at the double strand breaks and target sites, and Tag sequences are inserted in the target sites. Through the modification, the new safe and efficient CRISPR / Cas9 gene editing system which is specially used for the Kluyveromyces and can perform stable copying and expression in the Kluyveromyces and perform gene modification is established.
Owner:KANGMA SHANGHAI BIOTECH LTD

Prosuction of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of camelidae

A process is provided for the production of an antibody or a fragment or functionalized fragment thereof using a transformed lower eukaryotic host containing an example DNA sequence encoding the antibody or (functionalized) fragment thereof, wherein the antibody or (functionalized) fragment thereof is derived from a heavy chain immunoglobulin of Camelidae and is devoid of light chains, and wherein the lower eukaryotic host is a mould, preferably belonging to the genera Aspergillus or Trichoderma, or a yeast, preferably belonging to the yeast genera Saccharomyces, Kluyveromyces, Hansenula, or Pichia. The heavy chain fragment can contain at least the whole variable domain. A complementary determining region (CDR) different from the CDR belonging to the natural antibody ex Camelidae can be grafted on the framework of the variable domain of the heavy chain immunoglobulin. The catalytic antibodies can be raised in Camelidae against transition state molecules. The functionalized antibody or fragment thereof can comprise a fusion protein of both a heavy chain immunoglobulin from Camelidae or a fragment thereof and another polypeptide, e.g., an enzyme, preferably an oxido-reductase. Also provided are new products obtainable by a process as described, and compositions containing a product produced by a process as described, which composition may contain a new product as provided.
Owner:BAC IP

Method for producing ethanol by synchronously saccharifying and fermenting Jerusalem artichoke raw material

The invention belongs to the biotechnology field, in particular to a method of manufacturing ethanol by utilizing Jerusalem artichoke material. The method comprises the following steps: in material process step, the fresh Jerusalem artichoke is cleaned and juiced, or sliced up, dried and pulverized; in a seed liquid preparation step, kluyveromyces are cultivated in seed culture fluid taking Jerusalem artichoke powders or Jerusalem artichoke juice as a complete composition; in a ferment step, seed liquid is inoculated in culture medium confected by the complete Jerusalem artichoke powders or the complete Jerusalem artichoke juice, the ethanol is produced through anaerobic fermentation, and the ethanol is obtained by distillation at last. Both compositions of a seed culture medium and a ferment culture medium provided by the method are Jerusalem artichoke powders or Jerusalem artichoke juice; any auxiliary composition is not needed; and beforehand saccharification processing of Jerusalem artichoke material in the ferment culture medium is not needed; inulase excreted by the kluyveromyces in the seed liquid directly hydrolyzes and saccharifys multi fructosan in the Jerusalem artichoke material; the ferment is processed at the same time; and concentration of ethanol product is high to 12 percent (v/v). The method has the advantages that the method is simple; the synchronization process of saccharification and ferment is implemented; and the production cost is reduced.
Owner:FUDAN UNIV

Micro-ecological complex bacterial agent and method of preparing micro-ecological complex bacterial agent

InactiveCN101406489APromote digestion and absorptionTo achieve long-term effectivenessFungiBacteriaHigh concentrationBiotechnology
The invention relates to a micro-ecological composite fungus preparation and a method for preparing the same, in particular to a micro-ecological preparation and a method for preparing the same. The method solves the problems that the prior micro-ecological preparation can only temporarily increase and supplement the amount of probiotics in intestinal canal of a human body in a short period, and has poor competitiveness and viability so that the probiotics are used up after a period of time of stopping taking the micro-ecological preparation. The micro-ecological composite fungus preparation mainly comprises bacillus natto, lactic acid kluyveromyces, lactobacillus acidophilus and soybean oligosaccharides. The method comprises the following steps: culturing micro-ecological funguses; intermediately culturing the micro-ecological funguses; culturing and centrifuging the micro-ecological funguses after the micro-ecological funguses are transferred into a high concentration culture fluid; and adding auxiliary materials to the micro-ecological funguses, pre-freezing and vacuum freeze-drying the mixture, and adding the soybean oligosaccharides to the mixture to obtain the micro-ecological composite fungus preparation. The total number of viable beneficial bacteria in the micro-ecological composite fungus preparation is between 1.0 x 10<10> and 9.9 x 10<10> per gram, the micro-ecological composite fungus preparation not only has huge unit number, but also has high survival rate of the viable bacteria of more than 98 percent two years later.
Owner:INST OF MICROBIOLOGY HEILONGJIANG ACADEMY OF SCI

Porcine circovirus type II virus-like particle vaccine and preparation method thereof

ActiveCN106399350AReduce clinical symptoms associated with infection with PCV2Reduce associated clinical symptomsFungiViral antigen ingredientsHigh densityGenus Kluyveromyces
The invention provides a kluyveromyces marxianus engineering bacterium obtained from recombinant expression of porcine circovirus type II capsid protein; and porcine circovirus type II virus-like particles are obtained by cloning porcine circovirus type II capsid protein genes into an expression vector and conducting recombinant expression in kluyveromyces marxianus. The invention also provides a preparation method of a porcine circovirus type II virus-like particle vaccine, wherein the preparation method comprises the following steps: preparing the porcine circovirus type II virus-like particles through high-density fermentation of the recombinant kluyveromyces marxianus, and then conducting separation and purification so as to prepare the vaccine. The porcine circovirus type II virus-like particle vaccine provided by the invention, which can generate a high-level serum IgG antibody just by implementing injection immunization once, has the advantages of being good in immunizing effect, high in safety, simple in culture operation, high in yield, low in production cost and the like, and the porcine circovirus type II virus-like particle vaccine can achieve large-scale enlarged production; and the porcine circovirus type II virus-like particle vaccine can be used for relieving and preventing related clinical symptoms caused by the infection of porcine circovirus type II (PCV2).
Owner:FUDAN UNIV

Prosuction of antibodies or (functionalized) fragments thereof derived from heavy chain immounogobulins of camelidae

A process is provided for the production of an antibody or a fragment or functionalized fragment thereof using a transformed lower eukaryotic host containing an example DNA sequence encoding the antibody or (functionalized) fragment thereof, wherein the antibody or (functionalized) fragment thereof is derived from a heavy chain immunoglobulin of Camelidae and is devoid of light chains, and wherein the lower eukaryotic host is a mould, preferably belonging to the genera Aspergillus or Trichoderma, or a yeast, preferably belonging to the yeast genera Saccharomyces, Kluyveromyces, Hansenula, or Pichia. The heavy chain fragment can contain at least the whole variable domain. A complementary determining region (CDR) different from the CDR belonging to the natural antibody ex Camelidae can be grafted on the framework of the variable domain of the heavy chain immunoglobulin. The catalytic antibodies can be raised in Camelidae against transition state molecules. The functionalized antibody or fragment thereof can comprise a fusion protein of both a heavy chain immunoglobulin from Camelidae or a fragment thereof and another polypeptide, e.g., an enzyme, preferably an oxido-reductase. Also provided are new products obtainable by a process as described, and compositions containing a product produced by a process as described, which composition may contain a new product as provided.
Owner:BAC IP

Acetic acid and xylose co-used Kluyveromyces marxianus strain and screening method

The invention discloses an acetic acid and xylose co-used Kluyveromyces marxianus strain with a biological preservation number of CGMCC No.16757. The strain is obtained by long-term orient domestication of Kluyveromyces marxianus through cellulosic hydrolysate and is prepared by the following steps: picking single yeast colonies from a YPD flat plate and carrying out 40 DEG C overnight culture; reinoculating collected cells to a fresh culture medium containing the cellulosic hydrolysate with certain concentration, enabling an optical density value of the culture medium at 620nm to be approximate to 0.3; culturing for 24 to 48 hours at 40 DEG C and 150rmp/min; when OD620 of the acetic acid and xylose co-used Kluyveromyces marxianus strain is greater than or equal to 2.0 (5 to 7 generations), collecting the cells; repeating the steps until the growth speed of the cells is obviously improved under the stress condition of an inhibitor with the concentration; improving the concentration ofthe cellulosic hydrolysate and starting new repeated culture; after continuous domestication, coating the YPD flat plate containing the cellulosic hydrolysate with the collected cells and culturing at40 DEG C for 24 to 48 hours; picking the single colonies with good growth situation and putting into a YPD liquid medium, and culturing at 40 DEG C and 150rmp/min for 24 to 48 hours; preserving dominant resistance clones in 30 percent glycerinum.
Owner:DALIAN UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products